Bay City Capital
Venture capital · San Francisco, California, United States
Portfolio collected from the firm’s website, last checked Jul 26, 2026.Raises and exits come from each company’s own SEC and company records.
5Deep-tech portfolio3 active
2Portfolio exitsAcquired or listed
0Raises, 12 monthsLatest: Relay Therapeutics
44Co-investorsShare a portfolio company
Portfolio · 5 companies
| Company | Sector | Status | Latest raise | Raised |
|---|---|---|---|---|
| Prelude Therapeutics | Biotech | Active | Aug 28, 2020 | $97.0M |
| Arcus Biosciences | Biotech | Active | — | — |
| Kymera Therapeutics | Biotech | Active | — | — |
| Relay Therapeutics | Biotech | Public | Jan 10, 2024 | $30.0M |
| Turning Point Therapeutics | Biotech | Acquired | — | — |
Peer ranks
Portfolio size#81
Portfolio exits#103
Raises, 12 months#88
Co-investors#39
Co-investors
- EcoR1 CapitalVenture capital4 shared
- The Column GroupVenture capital4 shared
- Biotechnology Value FundVenture capital3 shared
- Boxer CapitalVenture capital3 shared
- Alexandria Venture InvestmentsVenture capital2 shared
- Apple Tree PartnersVenture capital2 shared
- Brookside CapitalVenture capital2 shared
- Clarus VenturesVenture capital2 shared
- Deerfield Capital ManagementVenture capital2 shared
- Frazier Healthcare PartnersVenture capital2 shared
Sectors
- Biotech5
Portfolios are collected from investors’ own websites and matched to tracked deep-tech companies by name; duplicate listings of the same firm are merged. Exits and raises come from each company’s own record: Form D through the latest filing.